Workplace health, rethought

Your next long-term sick leave is already measurable today

Most workplace-health [BGM] programs measure participation. Aniva measures risk: cardiovascular, metabolic, brain and autoimmune disease. All from a single on-site appointment, visible in a dashboard that shows you where to act before risks become diagnoses.

GDPR-compliant [DSGVO] & clinically validated
On-site at your location, or at 50+ partner labs
Tax-deductible under §3(34) German Income Tax Act [§3 Nr 34 EStG] — up to €600 per employee/year, tax-free
Partnering with
Rethinking corporate wellness

Another workplace-health app no one opens?

With Aniva, you go beyond measuring participation into seeing risks and trends. Plus, your employees get a private insightful health dashboard to improve their wellbeing. Leading to better outcomes all around.

What wellness program
measures
Wellness program
reach
What employees get from
wellness program
How early you catch risks
from wellness trends
What wellness programs report
Biomarker-based

Aniva for employers

Workforce health trends while data stays private
Every employee benefits, not just the fit ones.
Everyone gets a personal, private plan.
Risks are caught early, while you can still act.
Long-term risk, where to act
Survey-based

Digital workplace-health apps

Self-reported surveys and step counts.
Mostly the already-motivated engage.
Generic articles and challenges.
Only after the employee self-reports.
Participation, NPS, steps
Activity-based

Urban sports & other activities

Studio check-ins to yoga or other classes.
Mostly the already-active engage.
A shared list of venues they can visit.
You cannot detect any risks from attendance.
Usage rate, satisfaction
How it works

One day. On site. Zero effort for your employees

Scheduling

We come to your location. One day, multiple shifts covered. No travel time, no downtime for your employees.

On-site blood draw

10 minutes per employee. Qualified staff, premium lab partners. Or alternatively at over 50 locations across Germany.

Individual reports

Every employee gets a complete, GDPR-compliant [DSGVO] health report with clear action recommendations.

Dashboard for HR & occupational medicine

Aggregated, anonymized risk heatmap of your workforce. You see where action is needed before it turns into absences.

Workforce risk analysis

What does the risk in your workforce look like?

We analyse the risk for you. Based on industry, age structure and company size, we estimate the hidden health risks in your workforce. Sources: RKI, DEGS1.

Four risk panels

What an Aniva screening finds in your workforce

Cardiovascular risk
Moderate

Cardiovascular disease, visible earlier than ever before

Heart-attack risk
Stroke risk
Heart failure
Hypertension
Metabolic risk
High

Metabolic risks, before they become diagnoses

Type 2 diabetes & pre-diabetes
Insulin resistance
Fatty liver disease (NAFLD)
Obesity-related downstream risks
Cognitive risk
Low

Brain & cognitive health

Alzheimer's / dementia risk
Cognitive exhaustion
Depression & burnout
Autoimmune risk
Moderate

Autoimmune disease, caught early

Thyroid dysfunction
Hashimoto's, rheumatic disease
Arthritis, MS
Psoriasis
The dashboard

You see exactly where your organization needs to act

Most workplace-health programs ask who shows up: they don't tell you who's getting sick. That's an expensive difference.

Methodology

What we look for

More than 20 clinically validated risk indications from a single on-site appointment. 46 biomarkers per employee, benchmarked against major published longitudinal studies.

26%
Heart
Out of range
11%
Autoimmune
In-range

Cardiovascular

Heart-attack risk
Stroke risk
Heart failure
Hypertension

Metabolic

Type 2 diabetes
Pre-diabetes
Insulin resistance
Fatty liver disease (NAFLD)
Obesity-related downstream risks

Brain

Alzheimer's / dementia
Cognitive exhaustion
Depression / burnout

Autoimmune

Thyroid dysfunction
Hashimoto's
Rheumatic disease / arthritis
Multiple sclerosis
Psoriasis
Validation

Aniva's risk models are continuously calibrated against major German and international longitudinal studies. Age- and industry-specific benchmarks are based on publicly available epidemiological data.

DEGS1
UK Biobank
RKI
Scientific advisory board

The people behind the methodology

Our risk models, biomarker panels and action recommendations are curated by an international team of physicians and life scientists.

Prof. Bruce W. Hollis, PhD

Biochemist

Chiara Herzog, PhD

Computational biologist

Prof. Dr. Caroline Stoakes

Nutritionist & MD

Jan Okoye-Weeg

Doctor & Sports Scientist
Next Step

Let's talk about what's hiding in your workforce